articleNew England Journal of MedicineMar 4, 2004Closed access

HIV Drug Resistance

Inserm · Hôpital Bichat-Claude-Bernard

PubMed
Indexed incrossrefpubmed

Abstract

Combinations of antiretroviral drugs have proven remarkably effective in controlling the progression of HIV disease and prolonging survival, but these benefits can be compromised by the development of drug resistance. About 50 percent of patients receiving antiretroviral therapy in the United States are estimated to harbor viruses that express resistance to at least one of the available antiretroviral drugs.

Citation impact

779
total citations
FWCI
17.89
Percentile
100%
References
96
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Antiretroviral drug
  • Drug resistance
  • Drug
  • Human immunodeficiency virus (HIV)
  • Antiretroviral therapy
  • ANTIRETROVIRAL AGENTS
  • HIV drug resistance
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.